Can essential fatty acids reduce the burden of disease(s)?

Coronary heart disease, stroke, diabetes mellitus, hypertension, cancer, depression schizophrenia, Alzheimer's disease, and collagen vascular diseases are low-grade systemic inflammatory conditions that are a severe burden on health care resources. Essential fatty acids (EFAs) and their metabol...

Descripción completa

Detalles Bibliográficos
Autor principal: Das, Undurti N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276500/
https://www.ncbi.nlm.nih.gov/pubmed/18348729
http://dx.doi.org/10.1186/1476-511X-7-9
_version_ 1782151996822781952
author Das, Undurti N
author_facet Das, Undurti N
author_sort Das, Undurti N
collection PubMed
description Coronary heart disease, stroke, diabetes mellitus, hypertension, cancer, depression schizophrenia, Alzheimer's disease, and collagen vascular diseases are low-grade systemic inflammatory conditions that are a severe burden on health care resources. Essential fatty acids (EFAs) and their metabolites: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), and arachidonic acid (AA) and their products: prostaglandin E(1), prostacyclin, lipoxins, resolvins, and protectins suppress inflammation, augment healing, and are of benefit in the prevention and management of these conditions. Hence, supplementation of EFAs could reduce burden of these disease(s).
format Text
id pubmed-2276500
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22765002008-03-29 Can essential fatty acids reduce the burden of disease(s)? Das, Undurti N Lipids Health Dis Hypothesis Coronary heart disease, stroke, diabetes mellitus, hypertension, cancer, depression schizophrenia, Alzheimer's disease, and collagen vascular diseases are low-grade systemic inflammatory conditions that are a severe burden on health care resources. Essential fatty acids (EFAs) and their metabolites: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), and arachidonic acid (AA) and their products: prostaglandin E(1), prostacyclin, lipoxins, resolvins, and protectins suppress inflammation, augment healing, and are of benefit in the prevention and management of these conditions. Hence, supplementation of EFAs could reduce burden of these disease(s). BioMed Central 2008-03-18 /pmc/articles/PMC2276500/ /pubmed/18348729 http://dx.doi.org/10.1186/1476-511X-7-9 Text en Copyright © 2008 Das; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hypothesis
Das, Undurti N
Can essential fatty acids reduce the burden of disease(s)?
title Can essential fatty acids reduce the burden of disease(s)?
title_full Can essential fatty acids reduce the burden of disease(s)?
title_fullStr Can essential fatty acids reduce the burden of disease(s)?
title_full_unstemmed Can essential fatty acids reduce the burden of disease(s)?
title_short Can essential fatty acids reduce the burden of disease(s)?
title_sort can essential fatty acids reduce the burden of disease(s)?
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276500/
https://www.ncbi.nlm.nih.gov/pubmed/18348729
http://dx.doi.org/10.1186/1476-511X-7-9
work_keys_str_mv AT dasundurtin canessentialfattyacidsreducetheburdenofdiseases

Ejemplares similares